Bank of America’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $63.1M | Buy |
840,598
+57,019
| +7% | +$4.5M | ﹤0.01% | 1444 |
|
|
2025
Q4 | $62M | Sell |
783,579
-71,716
| -8% | -$5.4M | ﹤0.01% | 1405 |
|
|
2025
Q3 | $56M | Sell |
855,295
-140,595
| -14% | -$6.86M | ﹤0.01% | 1655 |
|
|
2025
Q2 | $39.3M | Buy |
995,890
+228,458
| +30% | +$7.48M | ﹤0.01% | 1906 |
|
|
2025
Q1 | $23.2M | Buy |
767,432
+344,571
| +81% | +$11.3M | ﹤0.01% | 2290 |
|
|
2024
Q4 | $14.8M | Sell |
422,861
-145,799
| -26% | -$5.45M | ﹤0.01% | 2569 |
|
|
2024
Q3 | $22.8M | Buy |
568,660
+54,117
| +11% | +$2.52M | ﹤0.01% | 2277 |
|
|
2024
Q2 | $24.5M | Sell |
514,543
-91,755
| -15% | -$3.76M | ﹤0.01% | 2055 |
|
|
2024
Q1 | $26.3M | Buy |
606,298
+151,220
| +33% | +$7.21M | ﹤0.01% | 2015 |
|
|
2023
Q4 | $23M | Sell |
455,078
-80,966
| -15% | -$3.88M | ﹤0.01% | 2017 |
|
|
2023
Q3 | $24.3M | Buy |
536,044
+76,725
| +17% | +$3.17M | ﹤0.01% | 1837 |
|
|
2023
Q2 | $18.8M | Sell |
459,319
-173,325
| -27% | -$6.66M | ﹤0.01% | 2105 |
|
|
2023
Q1 | $22.6M | Sell |
632,644
-4,669
| -0.7% | -$175K | ﹤0.01% | 2003 |
|
|
2022
Q4 | $24.1M | Buy |
637,313
+77,357
| +14% | +$3.25M | ﹤0.01% | 1867 |
|
|
2022
Q3 | $24.8M | Sell |
559,956
-48,596
| -8% | -$2.05M | ﹤0.01% | 1782 |
|
|
2022
Q2 | $22.5M | Sell |
608,552
-153,606
| -20% | -$5.79M | ﹤0.01% | 1910 |
|
|
2022
Q1 | $28.2M | Buy |
762,158
+149,323
| +24% | +$4.89M | ﹤0.01% | 1825 |
|
|
2021
Q4 | $18.6M | Sell |
612,835
-97,282
| -14% | -$3.06M | ﹤0.01% | 2281 |
|
|
2021
Q3 | $23.8M | Sell |
710,117
-7,380
| -1% | -$278K | ﹤0.01% | 2018 |
|
|
2021
Q2 | $28.6M | Buy |
717,497
+25,914
| +4% | +$1.02M | ﹤0.01% | 1812 |
|
|
2021
Q1 | $31.1M | Buy |
691,583
+69,569
| +11% | +$3.88M | ﹤0.01% | 1659 |
|
|
2020
Q4 | $35.2M | Sell |
622,014
-234,808
| -27% | -$11.7M | ﹤0.01% | 1423 |
|
|
2020
Q3 | $40.7M | Buy |
856,822
+116,817
| +16% | +$6.49M | 0.01% | 1196 |
|
|
2020
Q2 | $43.6M | Sell |
740,005
-5,570
| -0.7% | -$310K | 0.01% | 1097 |
|
|
2020
Q1 | $35.3M | Sell |
745,575
-19,998
| -3% | -$1.11M | 0.01% | 1140 |
|
|
2019
Q4 | $46.2M | Sell |
765,573
-64,887
| -8% | -$3.87M | 0.01% | 1237 |
|
|
2019
Q3 | $49.8M | Sell |
830,460
-115,225
| -12% | -$7.51M | 0.01% | 1125 |
|
|
2019
Q2 | $60.8M | Buy |
945,685
+197,141
| +26% | +$13.9M | 0.01% | 1002 |
|
|
2019
Q1 | $60.8M | Sell |
748,544
-163,514
| -18% | -$10.5M | 0.01% | 998 |
|
|
2018
Q4 | $49.3M | Buy |
912,058
+152,844
| +20% | +$7.8M | 0.01% | 1002 |
|
|
2018
Q3 | $39.2M | Sell |
759,214
-137,532
| -15% | -$6.46M | 0.01% | 1283 |
|
|
2018
Q2 | $37.4M | Buy |
896,746
+53,503
| +6% | +$2.37M | 0.01% | 1295 |
|
|
2018
Q1 | $37.2M | Buy |
843,243
+7,734
| +0.9% | +$393K | 0.01% | 1268 |
|
|
2017
Q4 | $42M | Sell |
835,509
-579,581
| -41% | -$31.8M | 0.01% | 1207 |
|
|
2017
Q3 | $71.7M | Buy |
1,415,090
+526,994
| +59% | +$27.6M | 0.01% | 920 |
|
|
2017
Q2 | $45.2M | Sell |
888,096
-12,351
| -1% | -$575K | 0.01% | 1095 |
|
|
2017
Q1 | $36.2M | Sell |
900,447
-32,848
| -4% | -$1.48M | 0.01% | 1253 |
|
|
2016
Q4 | $44.6M | Buy |
933,295
+267,530
| +40% | +$10.6M | 0.01% | 1087 |
|
|
2016
Q3 | $24.4M | Sell |
665,765
-27,455
| -4% | -$859K | 0.01% | 1495 |
|
|
2016
Q2 | $16.1M | Sell |
693,220
-182,858
| -21% | -$5.9M | ﹤0.01% | 1752 |
|
|
2016
Q1 | $35.5M | Buy |
876,078
+100,071
| +13% | +$4.06M | 0.01% | 1140 |
|
|
2015
Q4 | $48.1M | Buy |
776,007
+79,144
| +11% | +$4.27M | 0.01% | 1020 |
|
|
2015
Q3 | $28.2M | Buy |
696,863
+360,705
| +107% | +$18.7M | 0.01% | 1357 |
|
|
2015
Q2 | $19.3M | Buy |
336,158
+187,043
| +125% | +$11.9M | 0.01% | 1428 |
|
|
2015
Q1 | $9.49M | Buy |
149,115
+101,272
| +212% | +$6.87M | ﹤0.01% | 1922 |
|
|
2014
Q4 | $2.95M | Sell |
47,843
-238,050
| -83% | -$11.7M | ﹤0.01% | 3014 |
|
|
2014
Q3 | $11.1M | Buy |
285,893
+152,493
| +114% | +$5.4M | ﹤0.01% | 1852 |
|
|
2014
Q2 | $4.59M | Sell |
133,400
-4,374
| -3% | -$138K | ﹤0.01% | 2644 |
|
|
2014
Q1 | $5.95M | Buy |
137,774
+36,306
| +36% | +$1.76M | ﹤0.01% | 2239 |
|
|
2013
Q4 | $4.04M | Buy |
101,468
+12,862
| +15% | +$458K | ﹤0.01% | 2653 |
|
|
2013
Q3 | $3.33M | Sell |
88,606
-17,475
| -16% | -$522K | ﹤0.01% | 2767 |
|
|
2013
Q2 | $2.85M | Buy |
+106,081
| New | +$2.26M | ﹤0.01% | 2823 |
|
Other funds holding IONS
VPM
VCM
Bank of America's IONS Position: Q1 2026 in Review
Bank of America increased its Ionis Pharmaceuticals (IONS) stake by 7.3% in Q1 2026, buying an estimated $4.5M and bringing the position to 840,598 shares worth $63.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1444.
Bank of America first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $71.7M in Q3 2017. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Bank of America held 840,598 shares of Ionis Pharmaceuticals worth $63.1M as of Q1 2026.
- Bank of America bought 57,019 Ionis Pharmaceuticals shares in Q1 2026, an estimated $4.5M.
- Ionis Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1444 holding.
- Bank of America first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Ionis Pharmaceuticals position peaked at $71.7M in Q3 2017.
- 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.